Who owns ABIOMED?

Key details on ABIOMED (Ticker: ABMD)

Who owns ABIOMED?

Is ABMD a good stock to own? Find out who bought ABIOMED, who sold ABIOMED (ABMD) stock, and who holds a large position in ABIOMED.

Fund Name Number of Shares Share Valuation As Of
PRIMECAP Management Company 5.69M $216.47M Dec. 31, 2014
Macquarie 3.50M $87.91M June 30, 2014
Essex Woodlands Health Ventures 3.15M $119.89M Dec. 31, 2014
Jackson Square Partners 3.02M $115.12M Dec. 31, 2014
Vanguard 2.51M $95.50M Dec. 31, 2014
Palo Alto Investors 2.46M $93.63M Dec. 31, 2014
BlackRock Fund Advisors 2.21M $84.08M Dec. 31, 2014
William Blair $ Company 1.88M $71.42M Dec. 31, 2014
Wellington Management Company 1.87M $71.36M Dec. 31, 2014
Tiger Global Management 1.69M $41.96M Sept. 30, 2014
Blue Mountain Capital Management 1.61M $41.87M March 31, 2014
Next Century Growth Investors 1.03M $39.21M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 1.02M $38.80M Dec. 31, 2014
Millennium Management 947170 $36.05M Dec. 31, 2014
Allianz Global Investors of America 903050 $20.04M March 31, 2012
Royal Bank of Canada 893266 $34.10M Dec. 31, 2014
LORD, ABBETT & CO 812680 $30.93M Dec. 31, 2014
Cortina Asset Management 802714 $30.55M Dec. 31, 2014
CR Intrinsic Investors 800000 $14.94M March 31, 2013
Norges Bank Investment Management 765302 $29.13M Dec. 31, 2014
STATE STREET CORPORATION 735469 $18.49M June 30, 2014

Who sold ABIOMED?

Fund Name Date Sold Number of Shares Sold Share Valuation
Columbus Circle Investors June 30, 2011 943204 $15.28M
Portolan Capital Management March 31, 2011 1.10M $15.92M